| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Oct 06, 2020 |
|||||||||
|
Levi Strauss
LEVI
|
Q3 FY20 | $0.08 | -$0.22 | $1.06B | $2.92B |
NYSE |
|||
| Q1 FY21 | $0.63 | $0.56 | $932.20M | $813.83M |
NASDAQ |
||||
|
Lifecore Biomedical
LFCR
|
- | -$0.11 | -$0.11 | $135.64M | - |
NASDAQ |
|||
|
Aytu BioPharma
AYTU
|
Q4 FY20 | -$4.00 | -$7.00 | $14.86M | $18.25M |
NASDAQ |
|||
|
Spire Global
SPIR
|
- | -$0.24 | - | $10.02M | - |
NYSE |
|||
|
Crown ElectroKinetics
CRKN
|
- | -$10.72 K | - | - | - |
NASDAQ |
|||
